543 related articles for article (PubMed ID: 33128490)
1. Efficacy and safety of remdesivir in hospitalized Covid-19 patients: Systematic review and meta-analysis including network meta-analysis.
Elsawah HK; Elsokary MA; Abdallah MS; ElShafie AH
Rev Med Virol; 2021 Jul; 31(4):e2187. PubMed ID: 33128490
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis.
Piscoya A; Ng-Sueng LF; Parra Del Riego A; Cerna-Viacava R; Pasupuleti V; Roman YM; Thota P; White CM; Hernandez AV
PLoS One; 2020; 15(12):e0243705. PubMed ID: 33301514
[TBL] [Abstract][Full Text] [Related]
3. Use of remdesivir in patients with COVID-19: a systematic review and meta-analysis.
Tanni SE; Silvinato A; Floriano I; Bacha HA; Barbosa AN; Bernardo WM
J Bras Pneumol; 2022; 48(1):e20210393. PubMed ID: 35137874
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of remdesivir in hospitalised COVID-19 patients: a systematic review and meta-analysis.
Angamo MT; Mohammed MA; Peterson GM
Infection; 2022 Feb; 50(1):27-41. PubMed ID: 34331674
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of remdesivir in COVID-19 caused by SARS-CoV-2: a systematic review and meta-analysis.
Singh S; Khera D; Chugh A; Khera PS; Chugh VK
BMJ Open; 2021 Jun; 11(6):e048416. PubMed ID: 34168031
[TBL] [Abstract][Full Text] [Related]
6. Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis.
Rezagholizadeh A; Khiali S; Sarbakhsh P; Entezari-Maleki T
Eur J Pharmacol; 2021 Apr; 897():173926. PubMed ID: 33549577
[TBL] [Abstract][Full Text] [Related]
7. Major Update: Remdesivir for Adults With COVID-19 : A Living Systematic Review and Meta-analysis for the American College of Physicians Practice Points.
Kaka AS; MacDonald R; Greer N; Vela K; Duan-Porter W; Obley A; Wilt TJ
Ann Intern Med; 2021 May; 174(5):663-672. PubMed ID: 33560863
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of remdesivir for the treatment of hospitalized COVID-19 persons: A network meta-analysis.
Jiang Y; Chen D; Cai D; Yi Y; Jiang S
J Med Virol; 2021 Feb; 93(2):1171-1174. PubMed ID: 32813283
[TBL] [Abstract][Full Text] [Related]
9. Remdesivir for Adults With COVID-19 : A Living Systematic Review for American College of Physicians Practice Points.
Wilt TJ; Kaka AS; MacDonald R; Greer N; Obley A; Duan-Porter W
Ann Intern Med; 2021 Feb; 174(2):209-220. PubMed ID: 33017170
[TBL] [Abstract][Full Text] [Related]
10. Remdesivir for the treatment of COVID-19: a living systematic review.
Verdugo-Paiva F; Acuña MP; Solá I; Rada G;
Medwave; 2020 Dec; 20(11):e8080. PubMed ID: 33361753
[TBL] [Abstract][Full Text] [Related]
11. Remdesivir: A potential game-changer or just a myth? A systematic review and meta-analysis.
Shrestha DB; Budhathoki P; Syed NI; Rawal E; Raut S; Khadka S
Life Sci; 2021 Jan; 264():118663. PubMed ID: 33121991
[TBL] [Abstract][Full Text] [Related]
12. Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials.
Al-Abdouh A; Bizanti A; Barbarawi M; Jabri A; Kumar A; Fashanu OE; Khan SU; Zhao D; Antar AAR; Michos ED
Contemp Clin Trials; 2021 Feb; 101():106272. PubMed ID: 33422642
[TBL] [Abstract][Full Text] [Related]
13. Remdesivir for the Treatment of Severe COVID-19: A Community Hospital's Experience.
Lee S; Santarelli A; Caine K; Schritter S; Dietrich T; Ashurst J
J Am Osteopath Assoc; 2020 Dec; 120(12):926-933. PubMed ID: 33136164
[TBL] [Abstract][Full Text] [Related]
14. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses.
WHO Solidarity Trial Consortium
Lancet; 2022 May; 399(10339):1941-1953. PubMed ID: 35512728
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy and safety of remdesivir in patients with COVID-19: a systematic review and network meta-analysis of randomized controlled trials.
Lai CC; Chen CH; Wang CY; Chen KH; Wang YH; Hsueh PR
J Antimicrob Chemother; 2021 Jul; 76(8):1962-1968. PubMed ID: 33758946
[TBL] [Abstract][Full Text] [Related]
16. Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care.
Olender SA; Perez KK; Go AS; Balani B; Price-Haywood EG; Shah NS; Wang S; Walunas TL; Swaminathan S; Slim J; Chin B; De Wit S; Ali SM; Soriano Viladomiu A; Robinson P; Gottlieb RL; Tsang TYO; Lee IH; Hu H; Haubrich RH; Chokkalingam AP; Lin L; Zhong L; Bekele BN; Mera-Giler R; Phulpin C; Edgar H; Gallant J; Diaz-Cuervo H; Smith LE; Osinusi AO; Brainard DM; Bernardino JI;
Clin Infect Dis; 2021 Dec; 73(11):e4166-e4174. PubMed ID: 32706859
[TBL] [Abstract][Full Text] [Related]
17. Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
Spinner CD; Gottlieb RL; Criner GJ; Arribas López JR; Cattelan AM; Soriano Viladomiu A; Ogbuagu O; Malhotra P; Mullane KM; Castagna A; Chai LYA; Roestenberg M; Tsang OTY; Bernasconi E; Le Turnier P; Chang SC; SenGupta D; Hyland RH; Osinusi AO; Cao H; Blair C; Wang H; Gaggar A; Brainard DM; McPhail MJ; Bhagani S; Ahn MY; Sanyal AJ; Huhn G; Marty FM;
JAMA; 2020 Sep; 324(11):1048-1057. PubMed ID: 32821939
[TBL] [Abstract][Full Text] [Related]
18. Ivermectin for preventing and treating COVID-19.
Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
[TBL] [Abstract][Full Text] [Related]
19. Remdesivir against COVID-19 and Other Viral Diseases.
Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
[TBL] [Abstract][Full Text] [Related]
20. Remdesivir for coronavirus disease 2019 (COVID-19): a systematic review with meta-analysis and trial sequential analysis of randomized controlled trials.
Okoli GN; Rabbani R; Copstein L; Al-Juboori A; Askin N; Abou-Setta AM
Infect Dis (Lond); 2021 Sep; 53(9):691-699. PubMed ID: 33974479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
